[1] MOSIER JA,SCHWAGER SC,BOYAJIAN DA,et al.Cancer cell metabolic plasticity in migration and metastasis［J］.Clinical & Experimental Metastasis,2021,38(4):343-359.
[2] MARJANOVIC ND,HOFREE M,CHAN JE,et al.Emergence of a high-plasticity cell state during lung cancer evolution［J］.Cancer Cell,2020,38(2):229-246.
[3] BAKIR B,CHIARELLA AM,PITARRESI JR,et al.EMT,MET,plasticity,and tumor metastasis［J］.Trends Cell Biol,2020,30(10):764-776.
[4] FEINBERG AP,LEVCHENKO A.Epigenetics as a mediator of plasticity in cancer［J］.Science,2023,379(6632):eaaw3835.
[5] KOBAYASHI T,CHANMEE T,ITANO N.Hyaluronan:metabolism and function［J］.Biomolecules,2020,10(11):1525.
[6] CAON I,BARTOLINI B,PARNIGONI A,et al.Revisiting the hallmarks of cancer:The role of hyaluronan［J］.Semin Cancer Biol,2020,62:9-19.
[7] ZHANG G,LU R,WU M,et al.Colorectal cancer-associated ~ 6 kDa hyaluronan serves as a novel biomarker for cancer progression and metastasis［J］.FEBS J,2019,286(16):3148-3163.
[8] DONELAN W,DOMINGUEZ-GUTIERREZ PR,KUSMARTSEV S.Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression［J］.Front Immunol,2022,13:971278.
[9] VASVANI S,KULKARNI P,RAWTANI D.Hyaluronic acid:A review on its biology,aspects of drug delivery,route of administrations and a special emphasis on its approved marketed products and recent clinical studies［J］.Int J Biol Macromol,2020,151:1012-1029.
[10] SHENG Y,CAO M,LIU Y,et al.Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells［J］.Mol Cell Biochem,2021,476(9):3383-3391.
[11] LOKESHWAR VB,MORERA DS,HASANALI SL,et al.A novel splice variant of HYAL-4 drives malignant transformation and predicts outcome in patients with bladder cancer［J］.Clinical Cancer Research,2020,26(13):3455-3467.
[12] DOMINGUEZ-GUTIERREZ PR,KWENDA EP,DONELAN W,et al.Hyal2 expression in tumor-associated myeloid cells mediates cancer-related inflammation in bladder cancer［J］.Cancer Res,2021,81(3):648-657.
[13] JIN Z,ZHANG G,LIU Y,et al.The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer［J］.J Gastroenterol Hepatol,2019,34(10):1766-1776.
[14] CARVALHO AM,REIS RL,PASHKULEVA I.Hyaluronan receptors as mediators and modulators of the tumor microenvironment［J］.Adv Healthc Mater,2023,12(5):e2202118.
[15] SANCHO P,BARNEDA D,HEESCHEN C.Hallmarks of cancer stem cell metabolism［J］.British Journal of Cancer,2016,114(12):1305-1312.
[16] JU F,ATYAH MM,HORSTMANN N,et al.Characteristics of the cancer stem cell niche and therapeutic strategies［J］.Stem Cell Res Ther,2022,13(1):233.
[17] LEE IC,WU YC,HUNG WS.Hyaluronic acid-based multilayer films regulate hypoxic multicellular aggregation of pancreatic cancer cells with distinct cancer stem-cell-like properties［J］.ACS Appl Mater Interfaces,2018,10(45):38769-38779.
[18] OHNO Y,SHINGYOKU S,MIYAKE S,et al.Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways［J］.Oncogene,2018,37(49):6357-6367.
[19] BI L,REN Y,FENG M,et al.HDAC11 regulates glycolysis through the LKB1/AMPK signaling pathway to maintain hepatocellular carcinoma stemness［J］.Cancer Res,2021,81(8):2015-2028.
[20] CHANMEE T,ONTONG P,IZUMIKAWA T,et al.Hyaluronan production regulates metabolic and cancer stem-like properties of breast cancer cells via hexosamine biosynthetic pathway-coupled HIF-1 signaling［J］.The Journal of Biological Chemistry,2016,291(46):24105-24120.
[21] SKANDALIS SS,KARALIS TT,CHATZOPOULOS A,et al.Hyaluronan-CD44 axis orchestrates cancer stem cell functions［J］.Cell Signal,2019,63:109377.
[22] CHEN L,FU C,ZHANG Q,et al.The role of CD44 in pathological angiogenesis［J］.FASEB Journal,2020,34(10):13125-13139.
[23] SKANDALIS SS,KARALIS T,HELDIN P.Intracellular hyaluronan:Importance for cellular functions［J］.Semin Cancer Biol,2020,62:20-30.
[24] GAO R,LI D,XUN J,et al.CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism［J］.Theranostics,2018,8(22):6248-6262.
[25] CHAFFER CL,SAN JUAN BP,LIM E,et al.EMT,cell plasticity and metastasis［J］.Cancer Metastasis Rev,2016,35(4):645-654.
[26] MARTINEZ-ORDOEZ A,DURAN A,RUIZ-MARTINEZ M,et al.Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer［J］.Cancer Cell,2023,41(2):252-271.
[27] ZHAO YF,QIAO SP,SHI SL,et al.Modulating three-dimensional microenvironment with hyaluronan of different molecular weights alters breast cancer cell invasion behavior［J］.ACS Appl Mater Interfaces,2017,9(11):9327-9338.
[28] 郝利铭,姜晶,赵广鑫，等.不同分子量透明质酸对肺癌小鼠体内肿瘤生长转移的影响［J］.吉林医药学院学报,2020,41(03):161-165.
HAO LM,JIANG J,ZHAO GX,et al.Effect of hyaluronic acid with different molecular weight on tumor growth and metastasis of lung cancer in mice［J］.Journal of Jilin Medical College,2020,41(03):161-165.
[29] GOMEZ KE,WU F,KEYSAR SB,et al.Cancer cell CD44 mediates macrophage/monocyte-driven regulation of head and neck cancer stem cells［J］.Cancer Res,2020,80(19):4185-4198.
[30] PORSCH H,BERNERT B,MEHIC M,et al.Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2［J］.Oncogene,2013,32(37):4355-4365.
[31] ODERO-MARAH V,HAWSAWI O,HENDERSON V,et al.Epithelial-mesenchymal transition (EMT) and prostate cancer［J］.Adv Exp Med Biol,2018,1095:101-110.
[32] KOLLIOPOULOS C,LIN CY,HELDIN CH,et al.Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer［J］.Matrix Biology,2019,80:29-45.
[33] ZHANG Z,TAO D,ZHANG P,et al.Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion［J］.J Exp Clin Cancer Res,2016,35(1):181.
[34] NGUYEN N,KUMAR A,CHACKO S,et al.Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition,micronucleation and centrosome abnormalities［J］.Cell Commun Signal,2017,15(1):48.
[35] JOLLY MK,PRECA BT,TRIPATHI SC,et al.Interconnected feedback loops among ESRP1,HAS2,and CD44 regulate epithelial-mesenchymal plasticity in cancer［J］.APL Bioeng,2018,2(3):031908.
[36] HASSN MESRATI M,SYAFRUDDIN SE,MOHTAR MA,et al.CD44:a multifunctional mediator of cancer progression［J］.Biomolecules,2021,11(12):1850.
[37] JOOSTEN SPJ,SPAARGAREN M,CLEVERS H,et al.Hepatocyte growth factor/MET and CD44 in colorectal cancer:partners in tumorigenesis and therapy resistance［J］.Biochim Biophys Acta Rev Cancer,2020,1874(2):188437.
[38] KODAN A,FUTAMATA R,KIMURA Y,et al.ABCB1/MDR1/P-gp employs an ATP-dependent twist-and-squeeze mechanism to export hydrophobic drugs［J］.FEBS Lett,2021,595(6):707-716.
[39] SUN X,TANG F,GUO Q,et al.HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer［J］.Front Pharmacol,2022,13:1031487.
[40] EBERT K,HAFFNER I,ZWINGENBERGER G,et al.Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2,SHB and HBEGF［J］.BMC Cancer,2022,22(1):254.
[41] TONG L,WANG Y,AO Y,et al.CREB1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis［J］.Biomed Pharmacother,2019,115:108891.
[42] DHAR D,ANTONUCCI L,NAKAGAWA H,et al.Liver cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling［J］.Cancer Cell,2018,33(6):1061-1077.
[43] MUYS BR,ANASTASAKIS DG,CLAYPOOL D,et al.The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma［J］.Genes & Development,2021,35(1-2):102-116.
[44] POTHURAJU R,RACHAGANI S,KRISHN SR,et al.Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance［J］.Molecular Cancer,2020,19(1):37.
[45] MIHANFAR A,FATTAHI A,NEJABATI HR.MicroRNA-mediated drug resistance in ovarian cancer［J］.J Cell Physiol,2019,234(4):3180-3191.
[46] BOURGUIGNON LYW.Matrix hyaluronan-CD44 interaction activates microRNA and lncRNA signaling associated with chemoresistance,invasion,and tumor progression［J］.Front Oncol,2019,9:492.
[47] RAJENDRAKUMAR SK,VENU A,REVURI V,et al.Hyaluronan-stabilized redox-sensitive nanoassembly for chemo-gene therapy and dual T1/T2 MR imaging in drug-resistant breast cancer cells［J］.Mol Pharm,2019,16(5):2226-2234.
[48] CHIKAMATSU K,ISHII H,TAKAHASHI G,et al.Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells［J］.Head Neck,2012,34(3):336-343.